Table II.
Univariate | Multivariate | |||
---|---|---|---|---|
Variables | P-value | Likelihood ratio P-value | Odds ratio (95% confidence interval) | Odds ratio P-value |
Procedure type (ORP vs. RARP) | 0.001b | <0.001b | Not convergent | 0.988 |
Age (<67 vs. ≥67 yearsa) | 0.067 | |||
BMI (<24 vs. ≥24 kg/m2a) | 0.061 | |||
Initial PSA (<7.55 vs. ≥7.55 ng/mla) | 0.022b | 0.091 | 0.44 (0.16 to 1.17) | 0.099 |
Preoperative sCre (<0.82 vs. ≥0.82 mg/dla) | 0.044b | 0.138 | 0.48 (0.18 to 1.29) | 0.147 |
Prostate volume (<29.9 vs. ≥29.9 mla) | 0.541 | |||
Pathological T stage (≤pT2 vs. ≥pT3) | 0.033b | 0.193 | 0.52 (0.19 to 1.38) | 0.187 |
Pathological N stage (0/x vs. 1) | 0.508 | |||
Pathological Gleason score (≤7 vs. ≥8) | 0.494 | |||
Surgical time (<231 vs. ≥231 mina) | <0.001b | 0.002b | 0.20 (0.07 to 0.64) | 0.006b |
Blood loss (<450 vs. ≥450 mla) | 0.115 | |||
Fluid infusion (<2100 vs. ≥2100 mla) | 0.745 |
aMedian data.
bStatistically significant data. ORP, open radical prostatectomy; RARP, robot-assisted radical prostatectomy; BMI, body mass index; PSA, prostate-specific antigen; sCre, serum creatinine.